La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

McMillan Shakespeare Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Rob De Luca

Amministratore delegato

AU$1.2m

Compenso totale

Percentuale dello stipendio del CEO	64.9%
Mandato del CEO	2.3yrs
Proprietà del CEO	n/a
Durata media del management	1.9yrs
Durata media del Consiglio di amministrazione	4.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

Feb 23

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

Jun 15

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Mar 06

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Oct 26

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Aug 31

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Jul 28

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Apr 01

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

Mar 06

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

Feb 09

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Jan 19

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

Jan 04

Is McMillan Shakespeare Limited (ASX:MMS) Trading At A 34% Discount?

Dec 20

At AU$11.83, Is McMillan Shakespeare Limited (ASX:MMS) Worth Looking At Closely?

Dec 06

Should We Be Cautious About McMillan Shakespeare Limited's (ASX:MMS) ROE Of 1.0%?

Nov 23

McMillan Shakespeare Limited (ASX:MMS) Insiders Increased Their Holdings

Sep 13

Is Now An Opportune Moment To Examine McMillan Shakespeare Limited (ASX:MMS)?

Aug 25

Investors Holding Back On McMillan Shakespeare Limited (ASX:MMS)

Aug 10

Does McMillan Shakespeare's (ASX:MMS) Statutory Profit Adequately Reflect Its Underlying Profit?

Aug 10

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Rob De Luca rispetto agli utili di McMillan Shakespeare?
Data	Compenso totale	Stipendio	Guadagni aziendali
Dec 31 2023	n/a	n/a	AU$76m
Sep 30 2023	n/a	n/a	AU$70m
Jun 30 2023	AU$1m	AU$805k	AU$64m
Dec 31 2022	n/a	n/a	AU$69m
Sep 30 2022	n/a	n/a	AU$68m
Jun 30 2022	AU$603k	AU$75k	AU$67m

Compensazione vs Mercato: La retribuzione totale di Rob ($USD 832.47K ) è circa la media per le aziende di dimensioni simili nel mercato Australian ($USD 1.07M ).

Compensazione vs guadagni: La retribuzione di Rob è aumentata di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Rob De Luca

2.3yrs

Mandato

AU$1,239,222

Compensazione

Mr. Roberto De Luca, also known as Rob, B Ec, MBA, serves as Managing Director and Chief Executive Officer of McMillan Shakespeare Limited since May 16, 2022. He served as Managing Director at Bank of West...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Roberto De Luca	MD, CEO & Director	2.3yrs	AU$1.24m	Nessun dato
Ashley Conn	CFO & Company Secretary	3.8yrs	AU$966.64k	Nessun dato
Wallace Yim	Chief Information Officer	3.6yrs	Nessun dato	Nessun dato
Helene Gordon	Chief People Officer	1.8yrs	Nessun dato	Nessun dato
Kylie Chambers	Chief Executive Officer of Group Remuneration Services	no data	Nessun dato	Nessun dato
Adam Morrison	Chief Executive Officer of Asset Management Services	1.2yrs	Nessun dato	Nessun dato
Himesha Jayasinghe	Sustainability Manager	no data	Nessun dato	Nessun dato
Denise Tung	Chief Digital Officer	1.9yrs	Nessun dato	Nessun dato
Anthony Vella	Chief Transformation Officer	1.6yrs	Nessun dato	Nessun dato
Verity Gilpin	Chief Executive Officer of Plan & Support Services	1.2yrs	Nessun dato	Nessun dato

1.9yrs

Durata media

Gestione esperta: Il team dirigenziale di MMS non è considerato esperto (durata media 1.9 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Roberto De Luca	MD, CEO & Director	2.3yrs	AU$1.24m	Nessun dato
Bruce Akhurst	Independent Non-Executive Director	3.3yrs	AU$148.85k	0.036% A$ 448.8k
John Bennetts	Non-Executive Director	20.7yrs	AU$116.05k	4.41% A$ 55.1m
Ross Chessari	Non-Executive Director	20.7yrs	AU$116.05k	Nessun dato
Helen Kurincic	Independent Non-Executive Chairman	5.9yrs	AU$212.04k	0.036% A$ 448.8k
Arlene Tansey	Independent Non-Executive Director	1.8yrs	AU$89.99k	Nessun dato
Kathryn Parsons	Independent Non-Executive Director	4.3yrs	AU$151.37k	0.019% A$ 242.3k

4.3yrs

Durata media

64yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di MMS sono considerati esperti (durata media dell'incarico 4.3 anni).

McMillan Shakespeare Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Mcmillan Shakespeare Limited Announces Chief Financial Officer Appointments

McMillan Shakespeare Limited, Annual General Meeting, Oct 27, 2023

Independent Non-Executive Chairman recently bought AU$62k worth of stock

McMillan Shakespeare Limited Appoints Arlene Tansey as Independent Non-Executive Director, Effective 7 November 2022

McMillan Shakespeare Limited Announces Retirement of Tim Poole From the Board of Directors, Effective 31 August 2022

McMillan Shakespeare Limited, Annual General Meeting, Oct 28, 2022

Recent updates

Mcmillan Shakespeare Limited Announces Chief Financial Officer Appointments

Upcoming dividend of AU$0.76 per share

First half dividend of AU$0.76 announced

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

McMillan Shakespeare Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 22%

Consensus EPS estimates increase by 16%

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

Price target decreased by 7.3% to AU$18.81

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

Upcoming dividend of AU$0.66 per share at 7.0% yield

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

Mcmillan Shakespeare Limited Announces Dividend for the Six Month Ended June 30, 2023, Payable on September22, 2023

New major risk - Financial position

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired Asset Finance Aggregation business of McMillan Shakespeare Limited.

Price target increased by 7.8% to AU$17.45

A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of AU$0.58 per share at 10.0% yield

First half 2023 earnings released: EPS: AU$0.48 (vs AU$0.39 in 1H 2022)

McMillan Shakespeare Limited, Annual General Meeting, Oct 27, 2023

Independent Non-Executive Chairman recently bought AU$62k worth of stock

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$0.74 per share

McMillan Shakespeare Limited Appoints Arlene Tansey as Independent Non-Executive Director, Effective 7 November 2022

McMillan Shakespeare Limited Announces Retirement of Tim Poole From the Board of Directors, Effective 31 August 2022

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to AU$13.63

McMillan Shakespeare Limited Declares Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on November 10, 2022

Investor sentiment improved over the past week

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Price target decreased to AU$13.01

Price target increased to AU$14.29

Price target decreased to AU$13.23

Upcoming dividend of AU$0.34 per share

McMillan Shakespeare Limited, Annual General Meeting, Oct 28, 2022

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

McMillan Shakespeare Limited Declares an Interim Fully Franked Dividend, Payable on 25 March 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of AU$0.31 per share

McMillan Shakespeare Limited (ASX:MMS) acquired Plan Tracker.

Full year 2021 earnings released: EPS AU$0.79 (vs AU$0.016 in FY 2020)

Price target increased to AU$14.84

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Non-Executive Director recently sold AU$1.5m worth of stock

New 90-day low: AU$11.30

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

First half 2021 earnings released: EPS AU$0.33 (vs AU$0.42 in 1H 2020)

McMillan Shakespeare Limited (ASX:MMS) acquired remaining 50% stake in Maxxia Limited for AUD 1.8 million.

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

McMillan Shakespeare Limited to Report Fiscal Year 2021 Results on Aug 24, 2021

Price target raised to AU$12.00

New 90-day high: AU$12.68

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

New 90-day high: AU$12.26